- Kelso previously acquired Stirling Anglian Pharmaceuticals and Velit Biopharma
- Kelso Pharma focuses on products across various therapeutic areas
- Kelso is backed by Apposite Capital
Kartesia has provided committed debt facilities to support Kelso Pharma’s acquisition of ALTURiX.
Kelso Pharma, which is backed by Apposite Capital, focuses on branded and generic products across various therapeutic areas.
